Reasons for direct-to-patient distribution in clinical trial supply 2016

This statistic displays the percentage of select reasons for utilizing direct-to-patient (DTP) distribution methods in the global clinical trial supplies market in 2016. According to the survey, 38 percent of respondents indicated that by using DTP they improved patient retention by increasing convenience.

Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016

Characteristic	Percentage of organizations
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Sources

Use Ask Statista Research Service

Release date

March 2017

More information

Region

Worldwide

Survey time period

March to December 2016

Number of respondents

230 respondents

Special properties

healthcare industry professionals*

Supplementary notes

Sums may not add up to exactly 100 percent due to rounding.
* The survey was conducted among industry experts from clinical operations, clinical trial supply logistics and packaging, as well as biopharma manufacturing and supply chain organizations, representing organizations from over 20 countries and clinical supply operations worldwide.

Citation formats